Viking Therapeutics, Inc. (VKTX) quarterly cash flow statement — complete operating, investing & financing history
| Metric | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 | Q1'24 | Q4'23 | Q3'23 | Q2'23 | Q1'23 | Q4'22 | Q3'22 | Q2'22 | Q1'22 | Q4'21 | Q3'21 | Q2'21 |
|---|
| Cash from Operations | -113.98M | -85.29M | -94M | -47.06M | -52.33M | -31.18M | -21.96M | -28.51M | -6.13M | -17.64M | -19.66M | -11.44M | -24.64M | -10.93M | -13.5M | -13.44M | -10.53M | -12.35M | -10.93M | -13.43M |
| Operating CF Margin % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Operating CF Growth % | -117.8% | -173.53% | -328.03% | -65.05% | -753.13% | -76.76% | -11.72% | -149.35% | 75.11% | -61.45% | -45.63% | 14.93% | -134.03% | 11.53% | -23.55% | -0.06% | 3.18% | -125.12% | -105.26% | -101.53% |
| Net Income | -158.32M | -157.66M | -90.79M | -65.56M | -45.63M | -35.42M | -24.94M | -22.25M | -27.36M | -24.61M | -22.53M | -19.23M | -19.53M | -19.56M | -15.77M | -17.43M | -16.1M | -12.36M | -13.24M | -15.38M |
| Depreciation & Amortization | -1.21M | 94K | 114K | -5.59M | 111K | 110K | 87K | 75K | 74K | 74K | 73K | 73K | 72K | 72K | 142K | 0 | 77K | 76K | 75K | 73K |
| Stock-Based Compensation | 10.34M | 8.59M | 7.34M | 13.55M | 11.35M | 5.67M | 8.98M | 7.08M | 7.98M | 4.08M | 4.48M | 4.62M | 3.57M | 2.16M | 1.94M | 2.22M | 2.36M | 1.43M | 1.6M | 1.49M |
| Deferred Taxes | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -3.15M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Cash Items | 35.22M | -1.79M | -2.02M | 3.34M | -3.1M | -4M | -5.06M | -5.41M | -2.78M | -2.67M | 12K | -1.92M | -349K | -75K | 195K | 511K | 686K | 767K | 939K | 1.06M |
| Working Capital Changes | 0 | 65.48M | -8.64M | 7.2M | -15.06M | 2.46M | -1.03M | -8.01M | 15.95M | 5.48M | 1.46M | 5.02M | -8.4M | 6.48M | -3K | 1.26M | 2.45M | -2.27M | -296K | -682K |
| Change in Receivables | 0 | 413K | 2.2M | -11K | 2.47M | -646K | 1.35M | -157K | 655K | -101K | 0 | -67K | 243K | 0 | 0 | 243K | 105K | 594K | 0 | 759K |
| Change in Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Change in Payables | 13.93M | 48.84M | -1.08M | -2.21M | -2.11M | 9.56M | -10.84M | 5.86M | -2.29M | 1.8M | 100K | 1.81M | -4.73M | 5.39M | -2.96M | 2.95M | 1.71M | -1.39M | -1.38M | -637K |
| Cash from Investing | 54.19M | 75.61M | 160.03M | 42.51M | 63.24M | 6.58M | 25.9M | -126.06M | -459.79M | 35.73M | -12.53M | -204.48M | 2.2M | 7.26M | 26.89M | 18.98M | 1.62M | 27.41M | 13.62M | 3.56M |
| Capital Expenditures | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| CapEx % of Revenue | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Acquisitions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Investing | 125.69M | 0 | 0 | 165.99M | 0 | 0 | 0 | 0 | 0 | 0 | -12.53K | 0 | 2.2K | 0 | 26.89K | 0 | 0 | 0 | 0 | 0 |
| Cash from Financing | 12.08M | 75.1M | 480K | 507K | 349K | 1M | 2.52M | 2.9M | 606.04M | 188K | -74K | 267.08M | 4.18M | 10.75M | 10K | -1.59M | -5.01M | 47K | -256K | 1.9M |
| Debt Issued (Net) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Equity Issued (Net) | 0 | 1.16M | 480K | 507K | 0 | -46.66M | 46.66M | -25K | 597.12M | 269.95M | 1.9M | 272.49M | -1.71M | 128K | 10K | -1.67M | -5.12M | 0 | -22K | 0 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share Repurchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -37K | 0 | 0 | -1.67M | -5.12M | 0 | 0 | 0 |
| Other Financing | 12.08M | 73.95M | 0 | 0 | 349K | 47.66M | -44.14M | 2.93M | 8.92M | -269.76M | -1.97M | -5.41M | 5.9M | 10.62M | 0 | 84K | 115K | 47K | -234K | 1.9M |
| Net Change in Cash | -47.69M | 65.43M | 66.5M | -4.06M | 11.26M | -23.67M | 6.43M | -151.66M | 140.06M | 18.33M | -32.33M | 51.16M | -18.27M | 7.22M | 13.18M | 3.77M | -13.92M | 15.11M | 2.44M | -7.98M |
| Free Cash Flow | -113.98M | -85.29M | -94M | -47.06M | -52.33M | -31.18M | -21.96M | -28.51M | -6.13M | -17.64M | -19.66M | -11.44M | -24.64M | -10.93M | -13.5M | -13.44M | -10.53M | -12.35M | -10.93M | -13.43M |
| FCF Margin % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| FCF Growth % | -117.8% | -173.53% | -328.03% | -65.05% | -753.13% | -76.76% | -11.72% | -149.35% | 75.11% | -61.45% | -45.63% | 14.93% | -134.03% | 11.53% | -23.55% | -0.06% | 3.18% | -125.12% | -105.26% | -101.53% |
| FCF per Share | -0.99 | -0.75 | -0.84 | -0.42 | -0.47 | -0.28 | -0.20 | -0.26 | -0.06 | -0.18 | -0.20 | -0.12 | -0.31 | -0.14 | -0.18 | -0.17 | -0.14 | -0.16 | -0.14 | -0.17 |
| FCF Conversion (FCF/Net Income) | 0.72x | 0.54x | 1.04x | 0.72x | 1.15x | 0.88x | 0.88x | 1.28x | 0.22x | 0.72x | 0.87x | 0.59x | 1.26x | 0.56x | 0.86x | 0.77x | 0.65x | 1.00x | 0.83x | 0.87x |
| Interest Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Taxes Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |